[Role of phosphatidylinositol signalling path in developing hormonal resistance in tumor cells]

M A Krasil'nikov1, V A Shatskaia

  • 1Research Institute of Carcinogenesis, N.N. Blokhin Center for Oncology Research, Russian Academy of Medical Sciences, Moscow.

Voprosy Onkologii
|June 1, 2001
PubMed

Insights

The phosphatidylinositol 3-kinase (PI3K) pathway regulates cell survival and hormone resistance. Long-term exposure to dexamethasone activates PI3K signaling, leading to cells that overcome growth inhibition.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Phosphatidylinositol 3-kinase (PI3K) is crucial for anti-apoptotic signaling and cell survival.
  • The PI3K pathway regulates cellular responses to hormones, including the development of resistance to steroid cytostatic hormones.

Purpose of the Study:

  • To investigate the role of the PI3K signaling pathway in cellular response to hormones.
  • To understand the development of resistance to steroid cytostatic hormones through PI3K pathway modulation.

Main Methods:

  • Exposure of transformed hamster fibroblasts (line 2PK) to dexamethasone for short-term and long-term periods.
  • Analysis of PI3K effector activation (MAP-kinase, protein kinase B/PKB).
  • Assessment of c-jun synthesis and AP-1 transcriptional factor activity.

Main Results:

  • Short-term dexamethasone exposure activated PI3K effectors (MAP-kinase, PKB) despite growth inhibition.
  • Long-term dexamethasone exposure (3 months) generated resistant cell subpopulations with high PI3K, MAP-kinase, and PKB activity.
  • Dexamethasone treatment, short- or long-term, enhanced PI3K activity and c-jun synthesis, a component of AP-1.

Conclusions:

  • Continuous PI3K activation by cytostatic hormones can restructure intracellular signaling.
  • This leads to a constitutive PI3K pathway, enabling cells to partially overcome proliferative blocks.
  • The PI3K pathway and its dependent transcription factors play a significant role in hormone resistance development.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...